通过ABC载体和药物耐药性介导的溶酶体药物隔离
1Department of Anatomy, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic.
Pharmaceutics
|October 29, 2025
概括
由 lysosomal ABC 载体介导的耐药性不太可能发生. 这些载体需要在溶酶体中大量的药物积累,可能会损害它们的功能,并否定在体外抗癌药物的疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 血膜上的ATP结合盒 (ABC) 载体是药物耐药性 (DR) 的成熟媒介.
- 新兴的理论提出,溶酶体膜ABC转运体通过在溶酶体内隔离抗癌药物,从而对DR有所贡献.
- 支持 lysosomal ABC 载体介导DR 的经验证据仍然很少,甚至在体外.
研究的目的:
- 从理论上评估 lysosomal ABC 载体活动对目标部位抗癌药物度的影响.
- 评估在体外条件下将 lysosomal sequestration 作为 DR 机制的可行性.
主要方法:
- 使用简化模型进行假设计算.
- 模拟的标准体外实验条件.
主要成果:
- 血ABC输送器需要适度的度梯度来减半药物度.
- Lysosomal ABC 载体需要巨大的度梯度来实现类似的减少,这意味着大量的药物积累.
- 预计广泛的溶酶体药物积累会损害溶酶体功能.
结论:
- 通过 lysosomal ABC 载体进行 DR 的拟议机制是可疑的,因为需要极端的药物度.
- 溶酶体内如此高的药物水平可能会损害它们的细胞功能.
- 瘤细胞不太可能在体外使用 lysosomal ABC 载体来抵抗化疗.
相关概念视频
ABC Transporters: Exporter
6.3K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.3K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.8K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.8K
Carrier-Mediated Transport
1.1K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.1K
ABC Transporters: Importer
3.4K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
3.4K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
1.6K
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.6K
Hepatic Drug Clearance: Role of Transporters
295
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
295


